204 related articles for article (PubMed ID: 21187059)
41. Liquorice and glycyrrhetinic acid increase DHEA and deoxycorticosterone levels in vivo and in vitro by inhibiting adrenal SULT2A1 activity.
Al-Dujaili EA; Kenyon CJ; Nicol MR; Mason JI
Mol Cell Endocrinol; 2011 Apr; 336(1-2):102-9. PubMed ID: 21184804
[TBL] [Abstract][Full Text] [Related]
42. Cholecystokinin activation: evidence for an ordered reaction mechanism for the tyrosyl protein sulfotransferase responsible for the peptide sulfation.
Frerot O; Vargas F
Biochem Biophys Res Commun; 1991 Dec; 181(3):989-96. PubMed ID: 1764108
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of Human Sulfotransferase 2A1-Catalyzed Sulfonation of Lithocholic Acid, Glycolithocholic Acid, and Taurolithocholic Acid by Selective Estrogen Receptor Modulators and Various Analogs and Metabolites.
Bansal S; Lau AJ
J Pharmacol Exp Ther; 2019 Jun; 369(3):389-405. PubMed ID: 30918069
[TBL] [Abstract][Full Text] [Related]
44. Spectrofluorometric assay for monoamine-preferring phenol sulfotransferase (SULT1A3).
Lu LY; Hsu YC; Yang YS
Anal Biochem; 2010 Sep; 404(2):241-3. PubMed ID: 20566371
[TBL] [Abstract][Full Text] [Related]
45. Interactions of the stereoisomers of alpha-hydroxytamoxifen with human hydroxysteroid sulfotransferase SULT2A1 and rat hydroxysteroid sulfotransferase STa.
Apak TI; Duffel MW
Drug Metab Dispos; 2004 Dec; 32(12):1501-8. PubMed ID: 15371299
[TBL] [Abstract][Full Text] [Related]
46. Selective role of sulfotransferase 2A1 (SULT2A1) in the N-sulfoconjugation of quinolone drugs in humans.
Senggunprai L; Yoshinari K; Yamazoe Y
Drug Metab Dispos; 2009 Aug; 37(8):1711-7. PubMed ID: 19420132
[TBL] [Abstract][Full Text] [Related]
47. para-Nitrophenyl sulfate activation of human sulfotransferase 1A1 is consistent with intercepting the E[middle dot]PAP complex and reformation of E[middle dot]PAPS.
Tyapochkin E; Cook PF; Chen G
J Biol Chem; 2009 Oct; 284(43):29357-64. PubMed ID: 19706609
[TBL] [Abstract][Full Text] [Related]
48. Kinetic analysis of bile acid sulfation by stably expressed human sulfotransferase 2A1 (SULT2A1).
Huang J; Bathena SP; Tong J; Roth M; Hagenbuch B; Alnouti Y
Xenobiotica; 2010 Mar; 40(3):184-94. PubMed ID: 20102295
[TBL] [Abstract][Full Text] [Related]
49. Effects of 3'-phosphoadenosine 5'-phosphate on the activity and folding of phenol sulfotransferase.
Yang YS; Tsai SW; Lin ES
Chem Biol Interact; 1998 Feb; 109(1-3):129-35. PubMed ID: 9566740
[TBL] [Abstract][Full Text] [Related]
50. Regulation of murine hepatic hydroxysteroid sulfotransferase expression in hyposulfatemic mice and in a cell model of 3'-phosphoadenosine-5'-phosphosulfate deficiency.
Barrett KG; Fang H; Gargano MD; Markovich D; Kocarek TA; Runge-Morris M
Drug Metab Dispos; 2013 Aug; 41(8):1505-13. PubMed ID: 23674610
[TBL] [Abstract][Full Text] [Related]
51. The human estrogen sulfotransferase: a half-site reactive enzyme.
Sun M; Leyh TS
Biochemistry; 2010 Jun; 49(23):4779-85. PubMed ID: 20429582
[TBL] [Abstract][Full Text] [Related]
52. Isolation and characterization of a stereospecific 3beta-hydroxysteriod sulfotransferase (pregnenolone sulfotransferase) cDNA.
Dufort I; Tremblay Y; Bélanger A; Labrie F; Luu-The V
DNA Cell Biol; 1996 Jun; 15(6):481-7. PubMed ID: 8672244
[TBL] [Abstract][Full Text] [Related]
53. Enzymology of human cytosolic sulfotransferases.
Falany CN
FASEB J; 1997 Mar; 11(4):206-16. PubMed ID: 9068609
[TBL] [Abstract][Full Text] [Related]
54. Sulfotransferase structural biology and inhibitor discovery.
Rath VL; Verdugo D; Hemmerich S
Drug Discov Today; 2004 Dec; 9(23):1003-11. PubMed ID: 15574316
[TBL] [Abstract][Full Text] [Related]
55. Lack of substrate inhibition in a monomeric form of human cytosolic SULT2A1.
Cook IT; Leyh TS; Kadlubar SA; Falany CN
Horm Mol Biol Clin Investig; 2010 Dec; 3(1):367-74. PubMed ID: 25961208
[TBL] [Abstract][Full Text] [Related]
56. Microsomal steroid sulfatase: interactions with cytosolic steroid sulfotransferases.
Kauffman FC; Sharp S; Allan BB; Burchell A; Coughtrie MW
Chem Biol Interact; 1998 Feb; 109(1-3):169-82. PubMed ID: 9566744
[TBL] [Abstract][Full Text] [Related]
57. Lack of substrate inhibition in a monomeric form of human cytosolic SULT2A1.
Cook IT; Leyh TS; Kadlubar SA; Falany CN
Horm Mol Biol Clin Investig; 2010 Dec; 3(1):357-366. PubMed ID: 21822453
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of M and P phenol sulfotransferase by analogues of 3'-phosphoadenosine-5'-phosphosulfate.
Rens-Domiano SS; Roth JA
J Neurochem; 1987 May; 48(5):1411-5. PubMed ID: 3470439
[TBL] [Abstract][Full Text] [Related]
59. 3'-Phosphoadenosine-5'-phosphosulfate: photoaffinity ligand for sulfotransferase enzymes.
Otterness DM; Powers SP; Miller LJ; Weinshilboum RM
Mol Pharmacol; 1991 Jan; 39(1):34-41. PubMed ID: 1987450
[TBL] [Abstract][Full Text] [Related]
60. Adenosine-5'-phosphosulfate kinase from Penicillium chrysogenum: ligand binding properties and the mechanism of substrate inhibition.
Renosto F; Martin RL; Segel IH
Arch Biochem Biophys; 1991 Jan; 284(1):30-4. PubMed ID: 1846515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
